Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data
Ann-Cathrine Froitzheim, Melina Sophie Kurte, Katja Gehrke, Sebastian Lempfert, Katja Hesse, Florian Kron · 2026
Read Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data by Ann-Cathrine Froitzheim, Melina Sophie Kurte, Katja Gehrke, Sebastian Lempfert, Katja Hesse, Florian Kron (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13631127.txt.
Description
Ann-Cathrine Froitzheim and five colleagues compared real-world hospital costs for two intensive treatments in Germany. Both treat diffuse large B-cell lymphoma. One is engineered CAR T-cell therapy. The other is the patient's own stem cell transplant. Drug prices usually dominate this debate. So the authors left out the CAR T product's purchase price. They compared everything else using insurance billing and national inpatient data.
Initial care cost modestly more for CAR T patients. Follow-up costs ran far lower. Average inpatient bills came in at less than half the transplant figure. Hospital stays were nearly identical, at about twenty-seven days. Side effect profiles differed. Low blood counts were common to both. The authors say payment debates miss much of the true cost picture.
Catalog record
| CREATOR | Ann-Cathrine Froitzheim, Melina Sophie Kurte, Katja Gehrke, Sebastian Lempfert, Katja Hesse, Florian Kron |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |